Increasing Number of Nail Salons to Augment the Nail Polish Market Growth

 

Nail Polish Market

Nail Polish is a lacquer used to decorate both fingernails and toenails. It is also used to protect the nail plates. Nail Polish is made using various chemical compositions such as pearls, resins, pigments, plasticizers, film formers, solvents, and thickening agents (such as stearalkonium hectorite) to bind other ingredients. It is available in multiple colors. The increase in the female population has boosted the demand for nail polish worldwide. Customers are choosing nail polish based on their choice of nail art.

The increasing population of working women and growing awareness among consumers about grooming is driving the growth of the cosmetic industry, which in turn is driving the nail polish market growth. In 2019, Nail polish generated sales of around US$ 552.51 million, accounting for around 40% of the nail products in the United States. Moreover, the increasing number of nail salons and increasing disposable income is another factor, which may lead to the market growth. Increased disposable income leads to increased spending on personal care & cosmetic products. According to Statista, in 2019, the per capita disposable income in the United States was US$ 45,579. Thus, with rising disposable income, the demand for nail salons is expected to increase in the near years.

However, due to growing health concerns, the use of harmful chemicals in the manufacturing of nail polish may hamper the nail polish market growth. Nail polish contains hazardous and toxic chemical ingredients such as dibutyl phthalate and toluene, which can adversely affect human health. Health risks, such as chronic health problems, reproductive health issues, etc., are associated with nail polish products. It is mandatory for cosmetic manufacturers (under section 740.1) to put a warning on the product about possible health hazards that can result from using a product, according to the United States Food and Drug Administration (FDA). Moreover, a label should contain a list of ingredients used in that product.

In terms of geography, the nail polish market can be divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Asia Pacific is expected to continue its dominance due to the increasing population of working women, which in turn increases the demand for nail polish products in the region. Key players operating in the market are adopting various strategies such as new product launches or business expansion to broaden their product portfolio, as well as market presence. For instance, in December 2019, Kay Beauty forayed into nail products and launched its first nail varnish collection with around 36 shades. Moreover, in October 2019, Hello Kitty and OPI launched a new limited-edition collection in India with around 25 shades.

 

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more